Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting 29.08.2025'.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Par Drugs and Chemicals Limited held a meeting on August 29, 2025, and approved several key items. The 26th Annual General Meeting (AGM) has been scheduled for Saturday, September 27, 2025, at 11:00 AM in Vadodara, Gujarat, with book closure from September 20 to September 27, 2025, and e-voting open from September 23 to September 26, 2025. The Board approved the appointment of M/s. Sarupria Somani & Associates as Statutory Auditor for FY 2025-26 at a fee of Rs. 2.25 lakh, re-appointed M/s. Siddhpura & Co. as Internal Auditor, and appointed M/s. DG Patel & Associates as Secretarial Auditor for a 5-year term (FY 2025-26 to FY 2029-30). The Board also approved the re-appointment of Mr. Falgun Vallabhbhai Savani as Chairman & Managing Director (retiring by rotation) and Mrs. Bintal Bhaveshkumar Shah as Independent Director for a second 5-year term beginning September 28, 2025. Additionally, the Board approved a remuneration of Rs. 24 lakh per annum for Independent Director Mr. Pravin Manjibhai Bhayani and authorized the purchase of a Tata Harrier vehicle worth approximately Rs. 29.30 lakh for the CEO's use.
This is largely a routine governance and AGM-related announcement with standard auditor and director appointments, so it should have minimal direct impact on the stock price. Shareholders should note the key AGM and e-voting dates to participate in voting on the proposed resolutions, including the re-appointment of the CMD and Independent Director.